Paradigm shift in transfusion practices during early COVID-19 pandemic: A single center retrospective study.

BACKGROUND

The advent of coronavirus disease 2019 (COVID-19) unveiled the worst national blood crisis that the United States had witnessed in over a decade. With the pandemic influencing the different stages of the acquisition of blood products outside the hospital setting, we aimed to explore the possible barriers contributing to the shortage of blood products within the medical community.

AIM

To assess the adherence to restrictive blood transfusion practices for patients in the COVID era and pre-COVID era.

METHODS

We conducted a retrospective cross-sectional study on hospitalized patients distinguishing the pattern of blood transfusion during the COVID and pre-COVID era in a community hospital. Data was tabulated to include the number of red blood cell (RBC) transfusions and if transfusions met restrictive blood transfusion criteria as per institutional guidelines. Chi-square was applied to test the statistical association between qualitative variables. Unpaired test and Mann Whitney test were applied respectively to test the mean difference of quantitative variables.

RESULTS

A total of 208 patients were included in the study, of which 108 were during COVID era and 100 were during pre-COVID era. The leading reason for admission in both the COVID era and pre-COVID era transfused patients was shortness of breath (53.7% and 36% = 0.001), followed by gastrointestinal bleeding (25.9% and 21% = 0.001). There was a higher percentage of RBC transfusions in the intensive care unit in the COVID-era group than in the pre-COVID era group (38.9% 22%, = 0.008). The restrictive transfusion criteria were met in 62% 79% in the COVID and pre-COVID eras, respectively ( = 0.008).

CONCLUSION

The COVID-era group received RBC transfusions with less stringent adherence to restrictive blood transfusion practices in comparison to pre-COVID era group.